France's drugmakers sign marketing accord with govt
France's drug industry association, the LEEM, has concluded negotiations with the public sector's representative body, the Economic Committee for Health Care Products (CEPS), for an accord on marketing visits to physicians and pharmacists who are based in clinics or hospitals. The previous version of this agreement, dating from 2004, already covers drugmakers/general practitioner relations.
The LEEM said that the agreement is unique in the European Union, because of the capacity of both the state and the pharmaceutical industry to work on continuously improving the information provided to health care professionals, such as the latest therapeutic progress.
Christian Lajoux, the drug industry group's president, said that the accord is "a constructive stage in a process of contractual regulation that is necessary for France in order to attract investment in the life sciences."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze